EyeD Pharma Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$50.8M
- Investors
-
14
EyeD Pharma General Information
Description
Developer of drug products designed to improve the quality of life of patients and decrease the side effects associated with actual therapies. The company's products work together with ophthalmologists to offer new routes of treatment to patients and also offer surgical products to doctors for their clinical practices, enabling ophthalmologists to improve their surgical practice and patients to get therapeutic assistance that is currently unavailable in the market.
Contact Information
Website
www.eyedpharma.comCorporate Office
- Rue Louis Plescia 9
- 4102 Seraing
- Belgium
Corporate Office
- Rue Louis Plescia 9
- 4102 Seraing
- Belgium
EyeD Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 22-Dec-2021 | $50.8M | Completed | Clinical Trials - Phase 1 | ||
| 4. Later Stage VC | 22-May-2019 | Completed | Clinical Trials - Phase 1 | |||
| 3. Later Stage VC | 03-Jul-2018 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC | 22-Jun-2016 | $2.21M | $2.99M | Completed | Startup | |
| 1. Angel (individual) | 20-Dec-2012 | $782K | $782K | Completed | Startup |
EyeD Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class D | ||||||||
| Category C | ||||||||
| Category C | ||||||||
| Ordinary | 427,917 | $6.77 | $6.77 | 1x | $6.77 | 7.57% | ||
| Ordinary | 393,500 | $5.64 | $5.64 | 1x | $5.64 | 6.96% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
EyeD Pharma Comparisons
Industry
Financing
Details
EyeD Pharma Competitors (20)
One of EyeD Pharma’s 20 competitors is Johnson&Johnson Innovative Medicine, a Venture Capital-Backed company based in Raritan, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Johnson&Johnson Innovative Medicine | Venture Capital-Backed | Raritan, NJ | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan |
EyeD Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
EyeD Pharma Patents
EyeD Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026022370-A1 | Injector for intraocular drug delivery device | Pending | 26-Jul-2024 | ||
| WO-2026022371-A1 | Retainer for intraocular drug delivery device | Pending | 26-Jul-2024 | ||
| EP-4518836-A1 | Insert for the treatment of dry eyes | Active | 06-May-2022 | ||
| EP-4518836-B1 | Insert for the treatment of dry eyes | Active | 06-May-2022 | ||
| WO-2023214027-A1 | Insert for the treatment of dry eyes | Inactive | 06-May-2022 | A61K9/0051 |
EyeD Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
EyeD Pharma Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Nomainvest | PE/Buyout | Minority | ||
| Angel (individual) | Minority |
EyeD Pharma FAQs
-
When was EyeD Pharma founded?
EyeD Pharma was founded in 2012.
-
Where is EyeD Pharma headquartered?
EyeD Pharma is headquartered in Seraing, Belgium.
-
What is the size of EyeD Pharma?
EyeD Pharma has 50 total employees.
-
What industry is EyeD Pharma in?
EyeD Pharma’s primary industry is Drug Discovery.
-
Is EyeD Pharma a private or public company?
EyeD Pharma is a Private company.
-
What is the current valuation of EyeD Pharma?
The current valuation of EyeD Pharma is .
-
What is EyeD Pharma’s current revenue?
The current revenue for EyeD Pharma is .
-
How much funding has EyeD Pharma raised over time?
EyeD Pharma has raised $88.1M.
-
Who are EyeD Pharma’s investors?
, , , Nomainvest, and are 5 of 14 investors who have invested in EyeD Pharma.
-
Who are EyeD Pharma’s competitors?
Johnson&Johnson Innovative Medicine, Pfizer (Vienna), Genentech, Ability Pharma, and Pfizer Pakistan are some of the 20 competitors of EyeD Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
